Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Insulin treatment exerts cardioprotective effect against reperfusion injury via inhibiting early reperfusion-induced CaMKII activation

View through CrossRef
Objectives Primary reperfusion therapies, including percutaneous coronary intervention (PCI) and thrombolysis, are the standard of care for treating myocardial infarction (MI). Paradoxically, however, the return of blood flow can also result in additional damage and complications, referred to as reperfusion injury. In ischemic/reperfused (I/R) heart, Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation has been implicated in triggering apoptotic signaling. We have previously found that insulin reduces I/R injury, but the mechanisms remain elusive. The present study was designed to determine whether early insulin treatment reduces the myocardial reperfusion injury at the onset of R and its mechanisms. Methods and Results Male adult SD rats were subjected to 30 min of MI followed by 3 h of R. A significant activation of CaMKII at 3 min of R was confirmed by increased phosphorylation of both CaMKII (1.4-fold) and PLBThr17 (9.7-fold). Insulin treatment (0.4U/kg/h, administrated 10 min before MI and during the first 10 min of R, intravenous) notably improved PI3K expression and pAkt/Akt ratio (p<0.01 vs Saline) and inhibited CaMKII activity at 3 min of R (pCaMKII/CaMKII, pPLBThr17/PLB, both p<0.01). At the end of 3 h of R, insulin group exhibited reduced I/R injury as evidenced by decreased apoptosis (TUNEL and activated caspase 3) and improved left ventricular developed pressure recovery (LVDP: 77.2%±2.9% vs 65.3%±2.5%, all p<0.05). Pretreatment with wortmannin partially abolished insulin's inhibition of CaMKII activity (p<0.01) and its reduction of reperfusion injury (decreased TUNEL, activated caspase 3 and increased LVDP, all p<0.05). Conclusion These data are the first to demonstrate that insulin inhibits CaMKII in the beginning of reperfusion, at least in part, through PI3K-Akt signaling and reduces reperfusion injury, which suggests that early insulin therapy when reperfusion is clinically performed exerts significant cardioprotection.
Title: Insulin treatment exerts cardioprotective effect against reperfusion injury via inhibiting early reperfusion-induced CaMKII activation
Description:
Objectives Primary reperfusion therapies, including percutaneous coronary intervention (PCI) and thrombolysis, are the standard of care for treating myocardial infarction (MI).
Paradoxically, however, the return of blood flow can also result in additional damage and complications, referred to as reperfusion injury.
In ischemic/reperfused (I/R) heart, Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation has been implicated in triggering apoptotic signaling.
We have previously found that insulin reduces I/R injury, but the mechanisms remain elusive.
The present study was designed to determine whether early insulin treatment reduces the myocardial reperfusion injury at the onset of R and its mechanisms.
Methods and Results Male adult SD rats were subjected to 30 min of MI followed by 3 h of R.
A significant activation of CaMKII at 3 min of R was confirmed by increased phosphorylation of both CaMKII (1.
4-fold) and PLBThr17 (9.
7-fold).
Insulin treatment (0.
4U/kg/h, administrated 10 min before MI and during the first 10 min of R, intravenous) notably improved PI3K expression and pAkt/Akt ratio (p<0.
01 vs Saline) and inhibited CaMKII activity at 3 min of R (pCaMKII/CaMKII, pPLBThr17/PLB, both p<0.
01).
At the end of 3 h of R, insulin group exhibited reduced I/R injury as evidenced by decreased apoptosis (TUNEL and activated caspase 3) and improved left ventricular developed pressure recovery (LVDP: 77.
2%±2.
9% vs 65.
3%±2.
5%, all p<0.
05).
Pretreatment with wortmannin partially abolished insulin's inhibition of CaMKII activity (p<0.
01) and its reduction of reperfusion injury (decreased TUNEL, activated caspase 3 and increased LVDP, all p<0.
05).
Conclusion These data are the first to demonstrate that insulin inhibits CaMKII in the beginning of reperfusion, at least in part, through PI3K-Akt signaling and reduces reperfusion injury, which suggests that early insulin therapy when reperfusion is clinically performed exerts significant cardioprotection.

Related Results

Huoxue Wentong Formula ameliorates myocardial infarction in rats through inhibiting CaMKII oxidation and phosphorylation
Huoxue Wentong Formula ameliorates myocardial infarction in rats through inhibiting CaMKII oxidation and phosphorylation
Abstract Background The Chinese medicine Huoxue Wentong Formula (HXWTF) was used to treat thoracic obstruction and angina pectoris in clinic, which has not been investigated in myo...
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Effects of simulated ischemia-reperfusion and atorvastatin on INa in rat left ventricular myocytes.
Objective To observe time dependent effects of simulated ischemia-reperfusion on transient sodium currents (INa) in rat left ventricular myocytes, and effects of ...
Calcium-Calmodulin Kinase II Mediates Digitalis-Induced Arrhythmias
Calcium-Calmodulin Kinase II Mediates Digitalis-Induced Arrhythmias
Background— Digitalis-induced Na + accumulation results in an increase in Ca 2+ i v...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract Introduction During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE: To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...

Back to Top